Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

被引:23
|
作者
Monz, Brigitta U. [1 ]
Sachs, Paul [2 ,3 ]
McDonald, Jeffrey [4 ]
Crawford, Bruce [5 ]
Nivens, Michael C. [6 ]
Tetzlaff, Kay [6 ,7 ]
机构
[1] Boehringer Ingelhelm GmbH, D-55216 Ingelheim, Germany
[2] Stamford Hosp, Stamford, CT 06902 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[4] Mapi Values, Boston, MA 02114 USA
[5] Mapi Values, Tokyo 1530064, Japan
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[7] Univ Tubingen, Dept Sports Med, Med Clin, D-72076 Tubingen, Germany
关键词
Cough and sputum assessment questionnaire; COPD; Chronic bronchitis; Exacerbations; Responsiveness; OBSTRUCTIVE PULMONARY-DISEASE; SMOKING-CESSATION; TIME-COURSE; BREATHLESSNESS; VALIDATION; MANAGEMENT; RECOVERY; SYMPTOMS;
D O I
10.1016/j.rmed.2009.10.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering from an acute exacerbation. The 20-item questionnaire with a 7-day recall assesses the frequency and severity of cough and sputum and their impact on everyday life in clinical (trial) settings. The four domains (cough/sputum symptom and impact) use scales from 0 to 100, with lower scores indicating higher symptom/impact levels. Methods: Outpatients were enrolled within 48 h of symptom onset of their exacerbation. Treatment was initiated at the discretion of the investigator, and patients observed for 6 weeks. During study visits, 59 eligible patients completed the CASA-Q at enrolment, week 1, 2 and 6. Responsiveness was assessed by calculating standardized effect sizes. Results: Of the 19 male and 40 female patients with a mean (standard deviation, SD) age of 61.1 (10.5) years, all were classified by their physician to have improved or recovered after six weeks. The mean (SD) CASA-Qsores for the cough symptom, cough impact, sputum symptom and sputum impact domains increased from 32.6 (21.0), 40.7 (22.4), 37.4 (20.1), 47.1 (24.2) at enrolment to 54.0 (19.8), 63.7 (21.3), 55.1 (19.0), 65.5 (20.5) at week 6, respectively. Standardized effect sizes for patients improved or recovered from their exacerbation at week 6 were above 1.0 for the cough domains and at least 0.77 for the sputum domains. Conclusions: The CASA-Q was responsive to symptom changes in patients recovering from an exacerbation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 50 条
  • [1] Responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in Patients with COPD and Chronic Bronchitis Recovering from Acute Exacerbations.
    Tetzlaff, K.
    Sachs, P.
    McDonald, J.
    Crawford, B.
    Nivens, M. C.
    Monz, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [2] RESPONSIVENESS OF THE COPD ASSESSMENT TEST (CAT) QUESTIONNAIRE DURING EXACERBATIONS OF COPD
    Agusti, A.
    Soler, J. J.
    Molina, J.
    Munoz, M. J.
    Garcia-Losa, M.
    Roset, M.
    Jones, P. W.
    Badia, X.
    VALUE IN HEALTH, 2011, 14 (07) : A541 - A541
  • [3] Frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production
    Karim, Khennouf
    Taright, Samya
    Fissah, Aziza
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Moxifloxacin in acute exacerbations of chronic bronchitis and COPD
    Gu, Wan-Jie
    JOURNAL OF THORACIC DISEASE, 2014, 6 (07) : E160 - E160
  • [5] Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
    Drozdovszky, Orsolya
    Barta, Imre
    Antus, Balazs
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Do Cough and Sputum Production Predict COPD Exacerbations? The Evidence Is Growing
    Martin, Clemence
    Burgel, Pierre-Regis
    CHEST, 2019, 156 (04) : 641 - 642
  • [7] Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
    Burgel, Pierre-Regis
    Nesme-Meyer, Pascale
    Chanez, Pascal
    Caillaud, Denis
    Carre, Philippe
    Peres, Thierry
    Roche, Nicolas
    CHEST, 2009, 135 (04) : 975 - 982
  • [8] Development and validation of a cough and sputum assessment questionnaire
    Crawford, Bruce
    Monz, Brigitta
    Hohlfeld, Jens
    Roche, Nicolas
    Rubin, Bruce
    Magnussen, Helgo
    Nivens, Chad
    Ghafouri, Mo
    McDonald, Jeff
    Tetzlaff, Kay
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1545 - 1555
  • [9] Genetic Regulators of Sputum Mucin Concentration Revealed by GWAS and Their Associations with Chronic Bronchitis and Acute Exacerbations of COPD
    Kelada, S. N.
    Van Buren, E.
    Radicioni, G.
    O'Neal, W. K.
    Dang, H.
    Kasela, S.
    Garudadri, S.
    Curtis, J. L.
    Han, M. K.
    Krishnan, J. A.
    Wan, E. S.
    Silverman, E. K.
    Hastie, A. T.
    Ortega, V. E.
    Lappalainen, T.
    Christenson, S.
    Li, Y.
    Cho, M. H.
    Kesimer, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [10] Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
    Miravitlles, Marc
    Kruesmann, Frank
    Haverstock, Daniel
    Perroncel, Renee
    Choudhri, Shurjeel H.
    Arvis, Pierre
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (06) : 1354 - 1360